カテゴリー： QYResearch, 世界

悪性腹水治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Malignant Ascites Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18661）・商品コード：DATA909X18661
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：97
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、悪性腹水治療の世界市場について調査・分析し、悪性腹水治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（穿刺、化学療法、外科的治療）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の悪性腹水治療市場動向
・主要企業別マーケットシェア
・悪性腹水治療の種類別市場規模2014-2019
（穿刺、化学療法、外科的治療）
・悪性腹水治療の用途別市場規模2014-2019
（病院、クリニック、その他）
・悪性腹水治療の北米市場：主要企業・種類別/用途別市場規模
・悪性腹水治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・悪性腹水治療の中国市場：主要企業・種類別/用途別市場規模
・悪性腹水治療の日本国内市場：主要企業・種類別/用途別市場規模
・悪性腹水治療の東南アジア市場：主要企業・種類別/用途別市場規模
・悪性腹水治療のインド市場：主要企業・種類別/用途別市場規模
・悪性腹水治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（PharmaCyte Biotech、Sequana Medical、BioVie、BD、GI Supply、Teva、Mylan、GE、Trion）
・悪性腹水治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Ascites Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study
PharmaCyte Biotech
Sequana Medical
BioVie
BD
GI Supply
Teva
Mylan
GE
Trion

Market segment by Type, the product can be split into
Paracentesis
Chemotherapy
Surgical Treatment

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players.
To present the Malignant Ascites Treatment development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Malignant Ascites Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Malignant Ascites Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Paracentesis
1.4.3 Chemotherapy
1.4.4 Surgical Treatment
1.5 Market by Application
1.5.1 Global Malignant Ascites Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Malignant Ascites Treatment Market Size
2.2 Malignant Ascites Treatment Growth Trends by Regions
2.2.1 Malignant Ascites Treatment Market Size by Regions (2019-2025)
2.2.2 Malignant Ascites Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Malignant Ascites Treatment Market Size by by Players
3.1.1 Global Malignant Ascites Treatment Revenue by by Players (2014-2019)
3.1.2 Global Malignant Ascites Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Malignant Ascites Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Malignant Ascites Treatment Key Players Head office and Area Served
3.3 Key Players Malignant Ascites Treatment Product/Solution/Service
3.4 Date of Enter into Malignant Ascites Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Malignant Ascites Treatment Market Size by Type (2014-2019)
4.2 Global Malignant Ascites Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Malignant Ascites Treatment Market Size (2014-2019)
5.2 Malignant Ascites Treatment Key Players in North America
5.3 North America Malignant Ascites Treatment Market Size by Type
5.4 North America Malignant Ascites Treatment Market Size by Application

6 Europe
6.1 Europe Malignant Ascites Treatment Market Size (2014-2019)
6.2 Malignant Ascites Treatment Key Players in Europe
6.3 Europe Malignant Ascites Treatment Market Size by Type
6.4 Europe Malignant Ascites Treatment Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Malignant Ascites Treatment Market Size (2014-2019)
7.2 Malignant Ascites Treatment Key Players in Asia-Pacific
7.3 Asia-Pacific Malignant Ascites Treatment Market Size by Type
7.4 Asia-Pacific Malignant Ascites Treatment Market Size by Application

8 International Players Profiles
8.1 PharmaCyte Biotech
8.1.1 PharmaCyte Biotech Company Details
8.1.2 Company Description and Business Overview
8.1.3 Malignant Ascites Treatment Introduction
8.1.4 PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (2014-2019))
8.1.5 PharmaCyte Biotech Recent Development
8.2 Sequana Medical
8.2.1 Sequana Medical Company Details
8.2.2 Company Description and Business Overview
8.2.3 Malignant Ascites Treatment Introduction
8.2.4 Sequana Medical Revenue in Malignant Ascites Treatment Business (2014-2019)
8.2.5 Sequana Medical Recent Development
8.3 BioVie
8.3.1 BioVie Company Details
8.3.2 Company Description and Business Overview
8.3.3 Malignant Ascites Treatment Introduction
8.3.4 BioVie Revenue in Malignant Ascites Treatment Business (2014-2019)
8.3.5 BioVie Recent Development
8.4 BD
8.4.1 BD Company Details
8.4.2 Company Description and Business Overview
8.4.3 Malignant Ascites Treatment Introduction
8.4.4 BD Revenue in Malignant Ascites Treatment Business (2014-2019)
8.4.5 BD Recent Development
8.5 GI Supply
8.5.1 GI Supply Company Details
8.5.2 Company Description and Business Overview
8.5.3 Malignant Ascites Treatment Introduction
8.5.4 GI Supply Revenue in Malignant Ascites Treatment Business (2014-2019)
8.5.5 GI Supply Recent Development
8.6 Teva
8.6.1 Teva Company Details
8.6.2 Company Description and Business Overview
8.6.3 Malignant Ascites Treatment Introduction
8.6.4 Teva Revenue in Malignant Ascites Treatment Business (2014-2019)
8.6.5 Teva Recent Development
8.7 Mylan
8.7.1 Mylan Company Details
8.7.2 Company Description and Business Overview
8.7.3 Malignant Ascites Treatment Introduction
8.7.4 Mylan Revenue in Malignant Ascites Treatment Business (2014-2019)
8.7.5 Mylan Recent Development
8.8 GE
8.8.1 GE Company Details
8.8.2 Company Description and Business Overview
8.8.3 Malignant Ascites Treatment Introduction
8.8.4 GE Revenue in Malignant Ascites Treatment Business (2014-2019)
8.8.5 GE Recent Development
8.9 Trion
8.9.1 Trion Company Details
8.9.2 Company Description and Business Overview
8.9.3 Malignant Ascites Treatment Introduction
8.9.4 Trion Revenue in Malignant Ascites Treatment Business (2014-2019)
8.9.5 Trion Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Malignant Ascites Treatment Key Market Segments
Table Key Players Malignant Ascites Treatment Covered
Table Global Malignant Ascites Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Paracentesis Figures
Table Key Players of Paracentesis
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Surgical Treatment Figures
Table Key Players of Surgical Treatment
Table Global Malignant Ascites Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Malignant Ascites Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Malignant Ascites Treatment Report Years Considered
Figure Global Malignant Ascites Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Malignant Ascites Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Malignant Ascites Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Malignant Ascites Treatment Market Share by Regions 2014-2019
Figure Global Malignant Ascites Treatment Market Share by Regions 2014-2019
Figure Global Malignant Ascites Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Malignant Ascites Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Malignant Ascites Treatment Market Share by by Players (2014-2019)
Figure Global Malignant Ascites Treatment Market Share by by Players in 2018
Table Global Malignant Ascites Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Malignant Ascites Treatment Product/Solution/Service
Table Date of Enter into Malignant Ascites Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Malignant Ascites Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Malignant Ascites Treatment Market Size Share by Type (2014-2019)
Figure Global Malignant Ascites Treatment Market Size Market Share by Type (2014-2019)
Table Global Malignant Ascites Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Malignant Ascites Treatment Market Size Share by Application (2014-2019)
Figure Global Malignant Ascites Treatment Market Size Market Share by Application (2014-2019)
Figure Global Malignant Ascites Treatment Revenue Market Share by Application in 2018
Figure North America Malignant Ascites Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Malignant Ascites Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Malignant Ascites Treatment Market Share (2018-2019)
Table North America Malignant Ascites Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Malignant Ascites Treatment Market Share by Type 2014-2019
Table North America Malignant Ascites Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Malignant Ascites Treatment Market Share by Application 2014-2019
Figure Europe Malignant Ascites Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Malignant Ascites Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Malignant Ascites Treatment Market Share (2018-2019)
Table Europe Malignant Ascites Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Malignant Ascites Treatment Market Share by Type 2014-2019
Table Europe Malignant Ascites Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Malignant Ascites Treatment Market Share by Application 2014-2019
Figure Asia-Pacific Malignant Ascites Treatment Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Malignant Ascites Treatment Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Malignant Ascites Treatment Market Share (2018-2019)
Table Asia-Pacific Malignant Ascites Treatment Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Malignant Ascites Treatment Market Share by Type 2014-2019
Table Asia-Pacific Malignant Ascites Treatment Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Malignant Ascites Treatment Market Share by Application 2014-2019
Table PharmaCyte Biotech Company Details
Table PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure PharmaCyte Biotech Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table PharmaCyte Biotech Recent Development
Table Sequana Medical Company Details
Table Sequana Medical Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Sequana Medical Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Sequana Medical Recent Development
Table BioVie Company Details
Table BioVie Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure BioVie Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table BioVie Recent Development
Table BD Company Details
Table BD Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure BD Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table BD Recent Development
Table GI Supply Company Details
Table GI Supply Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure GI Supply Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table GI Supply Recent Development
Table Teva Company Details
Table Teva Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Mylan Recent Development
Table GE Company Details
Table GE Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure GE Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table GE Recent Development
Table Trion Company Details
Table Trion Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Trion Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Trion Recent Development
Table Global Malignant Ascites Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Malignant Ascites Treatment Market Size Share by Regions (2019-2025)
Figure Global Malignant Ascites Treatment Market Size Share by Regions in 2025
Figure North America Malignant Ascites Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Malignant Ascites Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Malignant Ascites Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Malignant Ascites Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Malignant Ascites Treatment Market Size by Product (2019-2025)
Figure Global Malignant Ascites Treatment Market Size by Product in 2025
Table Global Malignant Ascites Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Malignant Ascites Treatment Market Size by Application (2019-2025)
Figure Global Malignant Ascites Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

PharmaCyte Biotech、Sequana Medical、BioVie、BD、GI Supply、Teva、Mylan、GE、Trion

★調査レポート[悪性腹水治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18661)販売に関する免責事項を必ずご確認ください。
★調査レポート[悪性腹水治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 悪性神経膠腫治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18662 / QYResearch / 2019年11月25日 / ※当調査レポートでは、悪性神経膠腫治療法の世界市場について調査・分析し、悪性神経膠腫治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、標的療法）、用途別（大人、子供）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の悪性神経膠腫治療法市場動向 ・主要企業別マーケットシェア ・悪性神経膠腫治療法の種類別市場規模2014-2019 （化学療法、放射線療法、標的療法） ・悪性神経膠腫治療法の用途別市場規模2014-2019 （大人、子供） ・悪性神経膠腫治療法の北米市場：主要企業・種類別/用途別市場規模 ・悪性神経膠腫治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Malignant glioma, a tumor derived from the nerve epithelium, is generally referred to as glioma, accounting for 40-50% of brain tumors, and is the most common intracranial malignant tumor.In 2018, the global Malignant Glioma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Malignant Glioma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Glioma Therapeutics development in North America, Europe and Asia-Pacific. The key...
  • 転移性悪性黒色腫療法の世界市場：規模・現状・予測2019-2025
    DATA909X18698 / QYResearch / 2019年11月25日 / ※当調査レポートでは、転移性悪性黒色腫療法の世界市場について調査・分析し、転移性悪性黒色腫療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫療法、標的療法、その他）、用途別（病院、医学研究機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の転移性悪性黒色腫療法市場動向 ・主要企業別マーケットシェア ・転移性悪性黒色腫療法の種類別市場規模2014-2019 （免疫療法、標的療法、その他） ・転移性悪性黒色腫療法の用途別市場規模2014-2019 （病院、医学研究機関、その他） ・転移性悪性黒色腫療法の北米市場：主要企業・種類別/用途別市場規模 ・転移性悪性黒色腫療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Heart metastatic malignant melanoma  is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, in order to reduce the cardiopulmonary compression.Chemotherapy and immunotherapy can be used in patients with better systemic status, but malignant melanoma is not sensitive to the former, while the latter has a certain effect on enhancing the patient's immunity.Radiotherapy can be used as an experimental therapy and can also confirm the presence or absence of cardiac metastasis.Arrhythmias...
  • 胆道閉鎖症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18226 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆道閉鎖症治療の世界市場について調査・分析し、胆道閉鎖症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆道閉鎖症治療市場動向 ・主要企業別マーケットシェア ・胆道閉鎖症治療の種類別市場規模2014-2019 （薬物治療、外科治療） ・胆道閉鎖症治療の用途別市場規模2014-2019 （病院、診療所、その他） ・胆道閉鎖症治療の北米市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary...
  • 慢性片頭痛治療の世界市場：規模・現状・予測2019-2025
    DATA909X18277 / QYResearch / 2019年11月25日 / ※当調査レポートでは、慢性片頭痛治療の世界市場について調査・分析し、慢性片頭痛治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、代替治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性片頭痛治療市場動向 ・主要企業別マーケットシェア ・慢性片頭痛治療の種類別市場規模2014-2019 （薬物治療、代替治療） ・慢性片頭痛治療の用途別市場規模2014-2019 （病院、診療所、その他） ・慢性片頭痛治療の北米市場：主要企業・種類別/用途別市場規模 ・慢性片頭痛治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics to migraine attacks.In 2018, the global Chronic Migraine Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Chronic Migraine Treatment status, future forecast, growth opportunity, key market and key...
  • シロアリ駆除の世界市場：規模・現状・予測2019-2025
    DATA909X19024 / QYResearch / 2019年11月25日 / ※当調査レポートでは、シロアリ駆除の世界市場について調査・分析し、シロアリ駆除の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非化学的駆除、化学的駆除）、用途別（商業、住宅、産業、農業）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のシロアリ駆除市場動向 ・主要企業別マーケットシェア ・シロアリ駆除の種類別市場規模2014-2019 （非化学的駆除、化学的駆除） ・シロアリ駆除の用途別市場規模2014-2019 （商業、住宅、産業、農業） ・シロアリ駆除の北米市場：主要企業・種類別/用途別市場規模 ・シロアリ駆除のヨーロッパ市場：主要企業・種類別/用途別市場規模...A defined liquid termite treatment, using an approved termiticide, requires you to trench and treat the foundation, drill and treat all slabs touching the house, drill and treat the front stoop on basement home and treat around the piers in a crawl space.In 2018, the global Termite Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Termite Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the...
  • 胞巣状横紋筋肉腫治療の世界市場：規模・現状・予測2019-2025
    DATA909X18151 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胞巣状横紋筋肉腫治療の世界市場について調査・分析し、胞巣状横紋筋肉腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（外科手術、化学療法、放射線療法）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胞巣状横紋筋肉腫治療市場動向 ・主要企業別マーケットシェア ・胞巣状横紋筋肉腫治療の種類別市場規模2014-2019 （外科手術、化学療法、放射線療法） ・胞巣状横紋筋肉腫治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・胞巣状横紋筋肉腫治療の北米市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Alveolar rhabdomyosarcoma (ARMS) is a type of soft tissue sarcoma that originates from the connective tissues of the body such as bone, muscle, cartilage, and ligaments.In 2018, the global Alveolar Rhabdomyosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Alveolar Rhabdomyosarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alveolar Rhabdomyosarcoma Treatment development in North America, Europe and Asia-Pacific. The key players covered in...

    • ◆H&Iグローバルリサーチのお客様（例）◆